These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 35054279)

  • 1. Parkinson's Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering.
    Lee SH; Park SM; Yeo SS; Kwon O; Lee MK; Yoo H; Ahn EK; Jang JY; Jang JH
    Diagnostics (Basel); 2022 Jan; 12(1):. PubMed ID: 35054279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Parkinson's Disease Subtypes and Related Attributes.
    Shakya S; Prevett J; Hu X; Xiao R
    Front Neurol; 2022; 13():810038. PubMed ID: 35677337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
    Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
    Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
    Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
    Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtypes of Parkinson's Disease: What Do They Tell Us About Disease Progression?
    Fereshtehnejad SM; Postuma RB
    Curr Neurol Neurosci Rep; 2017 Apr; 17(4):34. PubMed ID: 28324303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data.
    Brendel M; Su C; Hou Y; Henchcliffe C; Wang F
    NPJ Parkinsons Dis; 2021 Sep; 7(1):83. PubMed ID: 34535682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
    Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
    Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.
    Mestre TA; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Marinus J; Mollenhauer B; Postuma R; Rajalingam R; Rodríguez-Violante M; Simuni T; Surmeier DJ; Weintraub D; McDermott MP; Lawton M; Marras C
    J Parkinsons Dis; 2021; 11(2):395-404. PubMed ID: 33682731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pathophysiological Correlates of Parkinson's Disease Clinical Subtypes.
    Belvisi D; Fabbrini A; De Bartolo MI; Costanzo M; Manzo N; Fabbrini G; Defazio G; Conte A; Berardelli A
    Mov Disord; 2021 Feb; 36(2):370-379. PubMed ID: 33037859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
    Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
    BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonmotor features of Parkinson's disease subtypes.
    Marras C; Chaudhuri KR
    Mov Disord; 2016 Aug; 31(8):1095-102. PubMed ID: 26861861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in Parkinson's disease: Advances and strategies.
    Delenclos M; Jones DR; McLean PJ; Uitti RJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Biomarkers for Parkinson's Disease.
    He R; Yan X; Guo J; Xu Q; Tang B; Sun Q
    Front Aging Neurosci; 2018; 10():305. PubMed ID: 30364199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically relevant connectivity features define three subtypes of Parkinson's disease patients.
    Guo T; Guan X; Zhou C; Gao T; Wu J; Song Z; Xuan M; Gu Q; Huang P; Pu J; Zhang B; Cui F; Xia S; Xu X; Zhang M
    Hum Brain Mapp; 2020 Oct; 41(14):4077-4092. PubMed ID: 32588952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reliable subtyping of de novo Parkinson disease: biomarkers, medication effects and longitudinal progression.
    Sun C; Xu H; Zhang Y; Zhang Y
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38083250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
    Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
    JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New markers in Parkinson's disease.
    Bougea A
    Adv Clin Chem; 2020; 96():137-178. PubMed ID: 32362317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive function in different motor subtypes of Parkinson's disease: A systematic review protocol.
    Child B; Saywell I; da Silva R; Collins-Praino L; Baetu I
    Health Sci Rep; 2024 May; 7(5):e2092. PubMed ID: 38706802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose-Driven Approach.
    Marras C; Fereshtehnejad SM; Berg D; Bohnen NI; Dujardin K; Erro R; Espay AJ; Halliday G; Van Hilten JJ; Hu MT; Jeon B; Klein C; Leentjens AFG; Mollenhauer B; Postuma RB; Rodríguez-Violante M; Simuni T; Weintraub D; Lawton M; Mestre TA
    Mov Disord; 2024 Mar; 39(3):462-471. PubMed ID: 38243775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.